Clinical Trial Update: Terazosin And Metabolic Energetics in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating terazosin's effects on metabolic energetics in Parkinson's disease; status: not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Terazosin (terazosin)

Snippet

Sponsor: Nandakumar Narayanan | Conditions: Parkinson's Disease (PD) | Phase 2 | Status: NOT_YET_RECRUITING